Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis
Open Access
- 15 June 2012
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 111 (3), 412-418
- https://doi.org/10.1111/j.1464-410x.2012.11313.x
Abstract
What's known on the subject? and What does the study add? In renal cell carcinoma the role of lymphadenectomy (LND) is still controversial. Moreover, no firm consensus exists regarding the minimum number of lymph nodes that should be removed to obtain a satisfactory staging LND at the time of surgery. Our findings demonstrate that, when clinically indicated, staging LND in renal cell carcinoma should be extended. The removal of 15 lymph nodes might represent the lowest threshold to define a staging LND as adequate. More extended LND should be pursued if unfavourable clinical and pathological characteristics are evident at diagnosis and/or during surgery. Objective To investigate the staging of lymphadenectomy in renal cell carcinoma. No convincing data exist regarding the minimum number of lymph nodes that should be removed at the time of nephrectomy to ensure an accurate staging. Methods Between 1987 and 2011, 850 patients with renal cell carcinoma underwent either partial or radical nephrectomy plus lymph node dissection (LND) at a single tertiary care institution (TanyN0–1Many). Receiver operating characteristic curve coordinates were used to graph the probability of finding lymph node invasion according to the number of removed lymph nodes. Assuming that the likelihood of finding lymph node invasion according to the number of lymph nodes removed may be affected by patient characteristics, analyses were further stratified for clinical and pathological characteristics. Results The rate of lymph node metastases strongly correlated with the clinical and pathological characteristics of the patients. Fifteen lymph nodes need to be removed to achieve a 90% probability of detecting at least one metastatic lymph node. Only slight differences were recorded after stratification for clinical nodal status, the presence of metastases at diagnosis and pathological T stage. Finally, 13, 16 and 21 lymph nodes need to be removed to achieve a 90% probability of detecting lymph node invasion, if present, in the low risk (score 0–1), intermediate risk (score 2–3) and high risk (score 4–5) Mayo Clinic classification, respectively. Conclusion The removal of 15 lymph nodes represents the lowest threshold for considering a staging LND as adequate. More extended LND should be pursued if unfavourable clinical and pathological characteristics are evident at diagnosis and/or during surgery.Keywords
This publication has 17 references indexed in Scilit:
- Improving the Outcome for Invasive Bladder Cancer: The Debate Regarding Pelvic Lymphadenectomy Moves From If to HowEuropean Urology, 2011
- Lymph node dissection is not obsolete in clinically node-negative Renal Cell Carcinoma patientsEuropean Urology, 2011
- Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical TemplatesEuropean Urology, 2011
- EAU Guidelines on Renal Cell Carcinoma: The 2010 UpdateEuropean Urology, 2010
- Extent of Pelvic Lymph Node Dissection During Radical Cystectomy: Where and Why!European Urology, 2010
- Editorial CommentInternational Journal of Urology, 2009
- Evidence-based clinical practice guidelines for renal cell carcinoma (Summary - JUA 2007 Edition)International Journal of Urology, 2009
- Stage‐specific effect of nodal metastases on survival in patients with non‐metastatic renal cell carcinomaBJU International, 2008
- Impact of lymphadenectomy and nodal burden in renal cell carcinoma: Retrospective analysis of the National Surveillance, Epidemiology, and End Results databaseUrology, 2005
- A PROTOCOL FOR PERFORMING EXTENDED LYMPH NODE DISSECTION USING PRIMARY TUMOR PATHOLOGICAL FEATURES FOR PATIENTS TREATED WITH RADICAL NEPHRECTOMY FOR CLEAR CELL RENAL CELL CARCINOMAJournal of Urology, 2004